Santhera's Shareholders Approve all Board Proposals at Today's Extraordinary General Meeting
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Eva Kalias. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Investegate announcements from Santhera Pharmaceuticals Holdi, Santhera’s Shareholders Approve all Board Proposals at Today’s Extraordinary General Meeting
Pratteln, Switzerland, December 6, 2021 - Santhera Pharmaceuticals (SIX: SANN) is pleased to invite investors, shareholders, media representatives and interested parties to join a conference call
Ad hoc announcement pursuant to Art. 53 LR Vamorolone given throughout the study showed sustained efficacy across multiple endpoints over 48 weeks and the...
Ad hoc announcement pursuant to Art. 53 LR Vamorolone given throughout the study showed sustained efficacy across multiple endpoints over 48 weeks and the good safety and tolerability profile